These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 31111221)
1. Carcinoembryonic antigen level in the pancreatic juice is effective in malignancy diagnosis and prediction of future malignant transformation of intraductal papillary mucinous neoplasm of the pancreas. Hayakawa H; Fukasawa M; Sato T; Takano S; Kadokura M; Shindo H; Takahashi E; Hirose S; Kawakami S; Fukasawa Y; Maekawa S; Inoue T; Yamaguchi T; Nakayama Y; Kawaida H; Kono H; Mochizuki K; Kondo T; Ichikawa D; Enomoto N J Gastroenterol; 2019 Nov; 54(11):1029-1037. PubMed ID: 31111221 [TBL] [Abstract][Full Text] [Related]
2. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas. Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608 [TBL] [Abstract][Full Text] [Related]
3. Malignant potential and specific characteristics of pure main duct type intraductal papillary mucinous neoplasm. Fujita Y; Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Ueno M; Hayami S; Kobayashi R; Yanagisawa A; Yamaue H Eur J Surg Oncol; 2022 May; 48(5):1054-1061. PubMed ID: 34933794 [TBL] [Abstract][Full Text] [Related]
4. Surgical strategy for intraductal papillary mucinous neoplasms of the pancreas. Hirono S; Yamaue H Surg Today; 2020 Jan; 50(1):50-55. PubMed ID: 31807871 [TBL] [Abstract][Full Text] [Related]
5. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. Maire F; Voitot H; Aubert A; Palazzo L; O'Toole D; Couvelard A; Levy P; Vidaud M; Sauvanet A; Ruszniewski P; Hammel P Am J Gastroenterol; 2008 Nov; 103(11):2871-7. PubMed ID: 18775021 [TBL] [Abstract][Full Text] [Related]
6. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas. Kim JR; Jang JY; Kang MJ; Park T; Lee SY; Jung W; Chang J; Shin Y; Han Y; Kim SW J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866 [TBL] [Abstract][Full Text] [Related]
7. Value of repeated cytology for intraductal papillary mucinous neoplasms of the pancreas with high risk potential of malignancy: Is it a promising method for monitoring a malignant transformation? Koshita S; Noda Y; Kanno Y; Ogawa T; Masu K; Kusunose H; Sakai T; Murabayashi T; Kozakai F; Yonamine K; Miyamoto K; Endo K; Horaguchi J; Oikawa M; Tsuchiya T; Sawai T; Ito K Pancreatology; 2020 Sep; 20(6):1164-1174. PubMed ID: 32800646 [TBL] [Abstract][Full Text] [Related]
8. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms. Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845 [TBL] [Abstract][Full Text] [Related]
9. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas. Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H JAMA Surg; 2017 Mar; 152(3):e165054. PubMed ID: 28122068 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of 18-FDG PET/CT in Detecting Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Yamashita YI; Okabe H; Hayashi H; Imai K; Nakagawa S; Nakao Y; Yusa T; Itoyama R; Yama T; Umesaki N; Arima K; Miyata T; Chikamoto A; Baba H Anticancer Res; 2019 May; 39(5):2493-2499. PubMed ID: 31092444 [TBL] [Abstract][Full Text] [Related]
11. Is preoperative pancreatic juice cytology useful for determining therapeutic strategies for patients with intraductal papillary mucinous neoplasm of the pancreas? Nagayama R; Ueki T; Shimizu Y; Hijioka S; Nakamura M; Kitano M; Hara K; Masamune A; Kin T; Hanada K; Koshita S; Yamada R; Takenaka M; Itoi T; Yanagisawa A; Otuka T; Hirono S; Kanno A; Ideno N; Kuwahara T; Shimizu A; Kamata K; Asai Y; Takeyama Y J Hepatobiliary Pancreat Sci; 2024 Mar; 31(3):183-192. PubMed ID: 38084510 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy. Yamaguchi T; Shirai Y; Ishihara T; Sudo K; Nakagawa A; Ito H; Miyazaki M; Nomura F; Saisho H Cancer; 2005 Dec; 104(12):2830-6. PubMed ID: 16287152 [TBL] [Abstract][Full Text] [Related]
13. Pancreatic juice cytology with immunohistochemistry to detect malignancy and histologic subtypes in patients with branch duct type intraductal papillary mucinous neoplasms of the pancreas. Koshita S; Noda Y; Ito K; Kanno Y; Ogawa T; Masu K; Masaki Y; Horaguchi J; Oikawa M; Tsuchiya T; Sawai T; Uzuki M; Fujishima F Gastrointest Endosc; 2017 May; 85(5):1036-1046. PubMed ID: 27756613 [TBL] [Abstract][Full Text] [Related]
14. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648 [TBL] [Abstract][Full Text] [Related]
15. Role of pancreatic juice cytology in the preoperative management of intraductal papillary mucinous neoplasm of the pancreas in the era of international consensus guidelines 2012. Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Ideno N; Aso T; Miyasaka Y; Ueda J; Takahata S; Osoegawa T; Igarashi H; Ito T; Ushijima Y; Ookubo F; Oda Y; Mizumoto K; Tanaka M World J Surg; 2014 Nov; 38(11):2994-3001. PubMed ID: 25037612 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas. Daudé M; Muscari F; Buscail C; Carrère N; Otal P; Selves J; Buscail L; Bournet B World J Gastroenterol; 2015 Mar; 21(9):2658-67. PubMed ID: 25759534 [TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen levels in pancreatic juice are associated with histological subtypes of intraductal papillary mucinous neoplasm of the pancreas. Hayakawa H; Fukasawa M; Takano S; Shindo H; Takahashi E; Kawakami S; Fukasawa Y; Kuratomi N; Sato T; Kadokura M; Hirose S; Maekawa S; Inoue T; Yamaguchi T; Harai S; Kawaida H; Kono H; Mochizuki K; Enomoto N DEN Open; 2023 Apr; 3(1):e169. PubMed ID: 36247313 [TBL] [Abstract][Full Text] [Related]
18. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of septal thickness measurement on endoscopic ultrasound as a predictor of malignancy of branched-duct and mixed-type intraductal papillary mucinous neoplasm of the pancreas. Iwaya H; Hijioka S; Mizuno N; Kuwahara T; Okuno N; Tajika M; Tanaka T; Ishihara M; Hirayama Y; Onishi S; Ito A; Kuraoka N; Matsumoto S; Polmanee P; Shimizu Y; Yatabe Y; Niwa Y; Tamada K; Ido A; Hara K Dig Endosc; 2019 Nov; 31(6):672-681. PubMed ID: 30920028 [TBL] [Abstract][Full Text] [Related]
20. The safety and benefit of pancreatic juice cytology under ERCP in IPMN patients. Yoshioka T; Shigekawa M; Yamai T; Suda T; Kegasawa T; Iwahashi K; Ikezawa K; Sakamori R; Yakushijin T; Hiramatsu N; Tatsumi T; Takehara T Pancreatology; 2016; 16(6):1020-1027. PubMed ID: 27567445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]